Related Experiment Video
Updated: Jul 18, 2026

07:35
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
The current and future therapy of allergic conjunctivitis
1Division of Ophthalmology, Scripps Clinic, La Jolla, CA 92037, USA.
Current Opinion in Ophthalmology
|July 1, 1999
Summary
Ocular allergy treatments include antihistamines, mast cell stabilizers, and NSAIDs for mild cases. Severe cases may require topical corticosteroids, with final drug selection based on symptoms, availability, and cost.
Area of Science:
- Ophthalmology
- Allergology
- Pharmacology
Background:
- Numerous antiallergic medications exist for ocular allergies, with more anticipated.
- Pharmaceutical companies pursue anti-inflammatory drug approvals for allergic conditions due to straightforward clinical trials in ocular allergy.
- Mild to moderate allergic conjunctivitis can be safely managed with antihistamines, mast cell stabilizers, and nonsteroidal anti-inflammatory drugs.
Purpose of the Study:
- To review the current landscape of antiallergic drugs for ocular allergy.
- To discuss the selection criteria for antiallergic medications in clinical practice.
Main Methods:
- Literature review of available antiallergic drugs for ocular allergy.
- Analysis of drug classes and their indications for allergic conjunctivitis.
Main Results:
- Antihistamines, mast cell stabilizers, and NSAIDs are safe options for mild to moderate allergic conjunctivitis.
- Topical corticosteroids are indicated for more severe ocular allergies, with options offering reduced side effects.
- Drug selection is guided by approved indications, patient symptoms, drug availability, and cost.
Conclusions:
- A wide array of antiallergic drugs are available for ocular allergy, catering to various severity levels.
- The choice of treatment involves balancing drug efficacy, safety, patient-specific factors, and economic considerations.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

